New postulates of autoimmunity--are they bona fide?

The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.

Lupus·2013

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.

Lupus·2013

Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Lupus·2013

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.

Lupus·2013

Rheumatological manifestations occurring in patients with diabetes mellitus.

Scandinavian journal of rheumatology·2012

What constitutes uncertainty in systemic lupus erythematosus and rheumatoid arthritis?

Psychology & health·2012

The m6A reader IGF2BP2 promotes proinflammatory signaling in Lupus nephritis by recognizing STAT1 m6A modifications.

Autoimmunity·2026

Zinc finger protein 24 enhances the pro-inflammatory activities of Tc17 cells and Tc17.1 cells in mouse collagen-induced arthritis.

Autoimmunity·2026

Androgen-associated remodeling of pulmonary NK cells and sex-biased susceptibility in lupus-associated diffuse alveolar hemorrhage.

Autoimmunity·2026

Targeting IFN signaling as therapeutic option for lupus nephritis.

Autoimmunity·2026

Interleukin-2 is associated with cytopenias in systemic lupus erythematosus.

Autoimmunity·2026

Compound kushen injection inhibits immune evasion of hepatocellular carcinoma cells via reducing O-GlcNAcylation of Pd-L1.

Autoimmunity·2026

Allopurinol-Induced Leukocytoclastic Vasculitis With Systemic Inflammatory Response: A Case Report From Azerbaijan.

Cureus·2026

From inflammation to rupture: advances in the pathogenesis of pseudoaneurysm formation in Vascular Behçet's Disease.

Frontiers in immunology·2026

TREM2 as a central hub of neuroimmune-metabolic crosstalk in central nervous system disorders: from microglial biology to therapeutic targeting.

Frontiers in immunology·2026

The immune microenvironment and population heterogeneity in myasthenia gravis: implications for precision therapeutics.

Frontiers in immunology·2026

Autoimmunity: Molecular Mechanisms, Biomarkers, and Therapeutic Opportunities.

MedComm·2026

Molecular basis of post-translational neoantigen generation in rheumatoid arthritis: breaking immunological tolerance and implications for targeted therapy.

Frontiers in immunology·2026

Related Experiment Videos

New postulates of autoimmunity--are they bona fide?

Related Concept Videos

The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.

Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.

Rheumatological manifestations occurring in patients with diabetes mellitus.

What constitutes uncertainty in systemic lupus erythematosus and rheumatoid arthritis?

The m6A reader IGF2BP2 promotes proinflammatory signaling in Lupus nephritis by recognizing STAT1 m6A modifications.

Zinc finger protein 24 enhances the pro-inflammatory activities of Tc17 cells and Tc17.1 cells in mouse collagen-induced arthritis.

Androgen-associated remodeling of pulmonary NK cells and sex-biased susceptibility in lupus-associated diffuse alveolar hemorrhage.

Targeting IFN signaling as therapeutic option for lupus nephritis.

Interleukin-2 is associated with cytopenias in systemic lupus erythematosus.

Compound kushen injection inhibits immune evasion of hepatocellular carcinoma cells via reducing O-GlcNAcylation of Pd-L1.

Allopurinol-Induced Leukocytoclastic Vasculitis With Systemic Inflammatory Response: A Case Report From Azerbaijan.

From inflammation to rupture: advances in the pathogenesis of pseudoaneurysm formation in Vascular Behçet's Disease.

TREM2 as a central hub of neuroimmune-metabolic crosstalk in central nervous system disorders: from microglial biology to therapeutic targeting.

The immune microenvironment and population heterogeneity in myasthenia gravis: implications for precision therapeutics.

Autoimmunity: Molecular Mechanisms, Biomarkers, and Therapeutic Opportunities.

Molecular basis of post-translational neoantigen generation in rheumatoid arthritis: breaking immunological tolerance and implications for targeted therapy.

Related Experiment Videos

New postulates of autoimmunity--are they bona fide?

Related Concept Videos

Related Articles